The Valley Desk

NCT04912063 · Interventional trial

Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome

Overall registry status Terminated

Phase 1

Conditions Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov